Of the 22 strains with elevated imipenem minimum inhibitory concentrations (≥4 g/mL), 10 were cfiA-positive and out of these 5 carried activating insertion sequence (IS) elements in the upstream regions of the cfiA genes. However, resistant strains with cfiA genes but with no activating IS elements were found (n = 2) as well as a resistant strain with no cfiA gene. In the former the resistance phenotypes by Etest were heterogeneous, whilst in the latter no carbapenemase production was seen; both mechanisms have been rarely observed, examined and characterised. Interestingly, few (n = 3) nim-positive strains were found, including one metronidazole-resistant strain harbouring nimE activated by ISBf6, and two susceptible strains harbouring chromosomally located nim genes.
Introduction
Bacteroides spp. represent one of the most significant groups of anaerobic bacteria. They are important constituents of the intestinal microbiota, from where they can cause severe anaerobic infections ranging from those of the soft tissue and upper respiratory tract to sepsis and various abscesses [1] . Bacteroides spp. can harbour the highest number of antibiotic resistance mechanisms and have the highest antibiotic resistance prevalences among all pathogenic anaerobes [2] . Because of their special and usually long culture requirements, temporary records of antibiotic resistance rates is considered a good and recommended practice worldwide. Such monitoring was performed mostly in the USA [3] and Europe [4] , the latter under the organisation of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Antimicrobial Resistance in Anaerobic Bacteria (ESGARAB), whose name was changed to the ESCMID Study Group on Anaerobic Infections to cover a broader interest. The general trend is almost 100% resistance to penicillins, cephalosporins and tetracycline, a rising moderate resistance prevalence to cefoxitin, clindamycin and moxifloxacin, and very low prevalences for carbapenems, ␤-lactam/␤-lactamase combinations, metronidazole and tigecycline [3, 4] . Following antibiotic resistance monitoring for Bacteroides in 2000, molecular analyses were carried out to determine the metronidazole and carbapenem resistance mechanisms [5, 6] . These investigations demonstrated the roles of the nim and cfiA genes and their activating insertion sequence (IS) elements in metronidazole and carbapenem resistance mechanisms, respectively.
Carbapenem-resistant Bacteroides isolates usually belong to the Bacteroides fragilis group, with the cfiA resistance gene being chromosomal and the majority of cfiA-positive strains being susceptible phenotypically because of the lack of upregulating IS elements [1] . The best-characterised metronidazole resistance mechanism among Bacteroides strains is due to the nim genes (nimA-F) that may occur in all Bacteroides species, and they are either located on well-characterised plasmids or on the chromosome. The majority of nim-positive Bacteroides isolates studied harbour a nim gene and a corresponding IS element pair [6] . It is of interest that the cfiA-positive B. fragilis isolates form a subgroup within this species. The cfiA-negative and cfiA-positive strains are therefore often classified as Division I and II, respectively, and can be distinguished by differences in DNA-DNA homology rates and by molecular typing methods such as randomly amplified polymorphic DNA polymerase chain reaction (RAPD-PCR), ribotyping, multilocus enzyme electrophoresis, sequence typing and Please cite this article in press as: Sóki matrix-assisted laser-desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry [7] [8] [9] [10] [11] [12] . The Ambler class A cephalosporinase gene, cepA, and the enterotoxin bft genes were reported to occur exclusively in Division I strains [10] . This study investigated the prevalences of the cfiA and nim genes, the imipenem and metronidazole resistance mechanisms in the majority of Bacteroides strains reported in the 2008 European Bacteroides antibiotic resistance survey. in an anaerobic cabinet (Concept 400; Ruskinn Technology Ltd., Bridgend, UK) under a gas composition of 85% N 2 , 10% H 2 and 5% CO 2 for 48 h. Antibiotic resistance results were obtained from the susceptibility measurements done previously by the agar dilution method [4] or by Etest (bioMérieux, Marcy-l'Étoile, France) as recommended by the supplier. The following control strains were used: B. fragilis TAL3636 (cfiA); B. fragilis 638R (pIP417) (nimA); B. fragilis BF-8 (nimB); B. fragilis 638R (pIP419) (nimC); B. fragilis 638R (pIP421) (nimD); and B. fragilis 388 (nimE).
Materials and methods

Bacterial strains and cultivation
Real-time PCR detection of the cfiA and nim genes
Bacterial template DNA samples for the real-time PCR analysis were prepared by incubating 100 L of 0.5 McFarland turbidity suspensions at 100 • C for 10 min, which were stored at −30 • C until use. Real-time PCR experiments were carried out in an MXPro3000 instrument (Stratagene, Santa Clara, CA) with the following reaction setup: 1× MasterMix [iQ TM (Bio-Rad Hungary, Budapest, Hungary) with 1× EvaGreen ® (Biotium Inc., Hayward, CA) for nim; or Brilliant III (Stratagene/Agilent, Santa Clara, CA) for cfiA and bft], 0.7 M of each primer and 2 L of template DNA preparation in 10 L final volumes in 96-well PCR reaction plates. The nucleotide sequences of the newly used primers and the cycling conditions chosen during this study are shown in Table 1 . Positive reactions were identified by the starting amplification cycle, melting curves showing the correct melting temperatures, and in rare cases where it was required to compare the size of the products with those of the positive controls in 1.2% agarose gel electrophoresis.
Table 2
Analysis of the imipenem resistance mechanism of strains with elevated imipenem minimum inhibitory concentrations (MICs) (≥4 g/mL).
Strain
Imipenem MIC (g/mL) 
Analysis of the carbapenem and metronidazole resistance mechanisms by molecular methods
An analysis of the carbapenem and metronidazole resistance mechanisms was carried out as previously described [14, 15] . Imipenemase activities were recorded in a 50 mM NaPO 4 (pH 7.0) buffer using sonicated cell extracts and 0.1 mM imipenem by following absorbance changes at 299 nm. Protein concentrations were measured with a Quant-iT TM Protein Assay Kit using a Qubit ® Mini Fluorometer (Life Technologies Hungary Ltd., Budapest, Hungary). Tazobactam (10 g/mL) or 10 mM ethylene diamine tetra-acetic acid (EDTA) were used to inhibit the enzymes, and imipenemase activity was expressed as 1 nmol hydrolysed imipenem/min (1 U) standardised by the protein concentration of the sonicates. Nucleotide sequencing was performed using an automated sequencer as described previously [15] . The novel nucleotide sequence of ISBf11 was deposited in the GenBank database under accession no. GQ449386.
Results and discussion
Resistance mechanisms of Bacteroides strains with elevated imipenem minimum inhibitory concentrations (MICs)
Of the 640 Bacteroides strains included in this study, 22 had imipenem MICs ≥ 4 g/mL. Of the 486 B. fragilis strains examined, 43 were cfiA-positive, and from the 640 Bacteroides isolates examined 22 and 7 had imipenem MICs ≥4 g/mL and ≥16 g/mL, respectively. No non-fragilis Bacteroides strains were resistant to imipenem and only one cfiA-negative B. fragilis isolate was resistant. The results are summarised in Table 2 . Of the 10 B. fragilis strains with elevated imipenem MICs (4-8 g/mL), 4 (40.0%) were cfiA-positive, whilst 6 (85.7%) of the 7 imipenem-resistant (MIC ≥ 16 g/mL) B. fragilis isolates were cfiA-positive. Among the strains with elevated MICs and with cfiA genes, one harboured an IS element upstream of cfiA (B. fragilis IT15), and among the cfiA-positive and imipenem-resistant strains four harboured IS elements upstream of the resistance gene ( Table 2 ). The remaining two cfiA-positive isolates that were imipenem-resistant but without activating IS elements upstream of cfiA displayed a heterogeneous resistance phenotype using the imipenem Etest (see the example in Fig. 1) .
This study yielded similar prevalence values for the molecular mechanisms of imipenem resistance of B. fragilis strains as those in previous studies. Among the highly imipenem-resistant strains (MIC ≥ 16 g/mL), the cfiA genes are activated by IS elements (4 of 6 cfiA-positive), and among strains with elevated imipenem MICs (≥4 g/mL) the cfiA genes were enriched (26.7% compared with the commonly found 2-8%). The types of cfiA-activating IS elements were IS1187 (n = 2), IS614B (n = 1), and a novel IS element (n = ISBf11; GenBank accession no. GQ449386) for B. fragilis H3 that had 77% homology compared with IS614B (Table 2) . Bacteroides fragilis IT15 harboured IS4351 upstream of the cfiA gene, but its imipenem MIC was low (4 g/mL). This latter finding is in accordance with that of Podglajen et al. [8] who found that B. fragilis strains carrying IS4351 upstream of the cfiA genes also tended to have low imipenem MICs (16 g/mL) compared with other IS elements (IS942 and IS1186; MICs ≥ 64 g/mL). Previously we detected a probably low-activity Bacteroides promoter-like sequence in the upstream regions of the cfiA genes. According to this, our study and other studies detected elevated imipenemase activities in 'silent' cfiA-positive strains that could account for the imipenem MICs in such strains [14, 16] . However, some highly imipenem-resistant strains (n = 2) were also genetically silent, their cfiA genes not being activated by IS elements (Table 2 ). In these cases Etest susceptibility tests detected heterogeneous resistance phenotypes (Fig. 1) where, inside of confluent inhibition zones, resistant colonies or growth appeared. This phenomenon can be explained by activation of the cfiA genes by an as yet unidentified mechanism that boosts the carbapenemase activity of the strains. We previously described such heteroresistant strains from human faeces whose imipenem MICs and imipenemase activities displayed a relation. In contrast, the cfiA genes were not activated by IS elements [16] . For Bacteroides, we detected heterogeneously cefoxitin-resistant strains and hypothesised that the copy number of the corresponding cfxA resistance gene might be important [17] .
A cfiA-negative but imipenem-resistant B. fragilis isolate was identified in this study (B. fragilis FI37; Table 2 ). Such strains were also found previously, but the exact carbapenem resistance mechanism for these strains has not yet been clarified [18, 19] . An imipenemase assay of this strain did not reveal any activity, whilst the control B. fragilis TAL3636 strain produced 41.0 U/mg imipenemase activity that was inhibited by EDTA. The probable resistance mechanisms are penicillin-binding protein (PBP) affinity or permeability changes. previously [19] , and mutations of an endogenous efflux system (bmeABC) also affected the carbapenem susceptibilities of the carrying strains [20] .
Detection of nim genes and their relation to metronidazole resistance
Of the 640 Bacteroides strains, 21 had reduced susceptibility to metronidazole (MIC ≥ 4 g/mL) and only 3 (B. fragilis IT724 and IT797 and B. thetaiotaomicron HU66) harboured nim genes, with the following metronidazole MICs: 0.125 g/mL (B. fragilis IT797), 1 g/mL (B. fragilis IT724) and 256 g/mL (B. thetaiotaomicron HU66). An examination of the nim-mediated resistance mechanisms revealed that B. fragilis IT797 and IT724 harboured chromosomal nimA and nimC genes, respectively. By contrast, the nimE gene of B. thetaiotaomicron HU66 was located on an 8.3 kb (pBF388c-like) [15] plasmid and was activated by ISBf6 (data not shown). No nim-specific plasmids were detected in the two other strains (a 5.6 kb class III plasmid and no plasmid content were characteristic for B. fragilis IT797 and IT724, respectively). Furthermore, B. fragilis IT797 harboured IS1168 and IS1170, but these elements could not be mapped to the nimA gene by PCR mapping. From these results, it appears that the situation with nim-mediated metronidazole-resistant Bacteroides strains has changed in Europe compared with the previous study where 43 Bacteroides strains with reduced metronidazole susceptibility (MICs ≥ 4 g/mL; 3.3%) and 30 (2.0%) nim-positive strains were found [6] . The current situation in Europe is reminiscent of that in the USA where nim genes and metronidazole resistances were scarce for a long time [21] . The nim-negative but metronidazole-resistant Bacteroides strains found in the current study may have other resistance mechanisms (reduced uptake, nitroreductase and pyruvate-ferredoxin oxidoreductase activities, increased lactate dehydrogenase activity, or mutations that alter the carbohydrate utilisation affecting the redox state) which shortcut the detrimental cellular effects of this drug [2, [22] [23] [24] .
In conclusion, these results confirmed the present view of carbapenem and metronidazole resistance mechanisms of Bacteroides spp. but also provide new information regarding their current state and epidemiology in Europe in addition to newly described mechanisms such as non-carbapenemase-mediated imipenem resistance and chromosomal nim genes.
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